Production (Stage)
Cabaletta Bio, Inc.
CABA
$1.86
-$0.0751-3.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.30% | -6.39% | -10.97% | -10.20% | -19.92% |
| Total Depreciation and Amortization | 3.63% | 10.38% | -0.47% | 8.40% | 16.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.82% | -12.34% | 8.82% | 33.82% | 39.10% |
| Change in Net Operating Assets | -206.02% | -0.83% | 9,448.39% | 99.25% | -731.50% |
| Cash from Operations | -33.22% | -13.77% | 2.24% | 13.34% | -45.84% |
| Capital Expenditure | -108.78% | -48.62% | 67.14% | 5.17% | -338.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00% | -48.98% | -- | -- |
| Cash from Investing | -106.47% | -1.00% | -48.39% | 3,022.41% | -171.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 38.46% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 7,321.13% | -81.27% | -94.47% | -92.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -112.63% | 6,057.75% | -81.27% | -94.47% | -92.63% |
| Foreign Exchange rate Adjustments | 135.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -383.48% | 16.98% | -341.11% | 118.50% | -123.08% |